Product Details:
Payment & Shipping Terms:
|
Source: | Yeast | Molecular Weight: | 9.1kD |
---|---|---|---|
Endotoxin: | Less Than 5.0 EU/mg | Usage: | Cell Culture, Stem Cell Culture, Vaccine Research |
Production Type: | Recombinant Protein | ED50: | ≤1ng/ml |
Highlight: | Recombiannt Igtropin IGF 1 Long R3,Igtropin IGF 1 Long R3,Igtropin IGF 1 Long R3 9.1kD |
Recombiannt Igtropin IGF 1 Long R3 No Animal Component 9.1kD Molecular Weight
Description
Healthgen Bichtech is equiped with the world’s most advanced purfication facility and can produce high purity rhIGF-1 LR3. We can not only ensure the hign bioactivity but also the high purity, which can reach as high as more than 90%. In addition, we have the specific plant bioreactor, which ensure no animal-origin additive ingredients in the products. LR3 IGF-1 (Long Arg3 IGF-1) is an 83 amino acid analog of IGF-1 comprising the complete human IGF-1 sequence with the substitution of an Arg for the Glu at position 3 (hence R3), and a 13 amino acid extension peptide at the N-terminus. The rhIGF-1 LR3 has much higher stability and biological activity.
Quick Details
Product Name | Recombinant Insulin-Like Growth Factor 1, LR3 |
Source | Yeast |
Catalog No. | HYC007M01 |
Physical Appearance | White lyophilized powder |
Formulation | rhIGF-1 LR3 is lyophilized with saline. |
Purity | >90% |
Endotoxin | Less than 5.0 EU/mg |
Restrictions | FOR RESEARCH, LABORATORY AND MANUFACTURE USE ONLY. NOT INTENDED FOR DIRECT USE ON HUMANS. |
Advantages
1. Wuhan Healthgen Biotechnology Corp. has strong technical capacity, advanced and complete protein expression and purification technology. Independent research and development, pioneering and internationally advanced State-of-the-art platform called OryzHiExp has many advantages, such as high security, easy to scale, simple production process, green and environmental protection. Our company ensures standardized process as well as qualified products. We have established the world's largest large-scale production line with most advanced facilities of plant-origin protein. rhIGF-1 LR3 originated from rice, began in nature.
2. The rice endosperm specific expression platform is easy to be large-scale. The rice endosperm has the protein body, which can keeps proteins stability and bioactivity. At present, the production capacity is almost 1 kg / year.
Supplemental Description
Healthgen Biotech has strong technical force and advanced and complete protein expression and purification technology development and large-scale production facilities. Self-developed rice endosperm cell expression platform (OryzHiExp), which is domestic initiative and the international leader, has such advantages: high expression level, safety, scale-up easily, simple production process and environmental protection etc. After 10 years of unremitting efforts, Healthgen Biotech has established recombinant protein expression and purification technology platform to customize recombinant protein or peptide expression and purification process service for pharmaceuticals, health products, scientific research and industrial reagents. Using the OryzHiExp platform, Healthgen Biotech has achievements in developing and commercializing a series of medium ingredients, including recombinant human serum albumin(OsrHSA), recombinant α-1 antitrypsin(OsrhAAT), recombinant human lactoferrin(OsrhLF), recombinant human basic fibroblast growth factor (OsrhbFGF), recombinant human insulin-like growth factor-1 LR3(rhIGF-1 LR3) , recombinant human epidermal growth factor(rhEGF) and recombinant human fibronectin(OsrhFN), which can provide a full set of solutions for animal component free .
.
Contact Person: Ms. Abby
Tel: +86-15071115810
Fax: 86-27-59403933-59416006